Introduction to Scmom 2012 Athersys
Welcome to our comprehensive guide on Scmom 2012 Athersys. Athersys
Scmom 2012 Athersys Comprehensive Overview
Profitable commercialization is a key goal for all cell-based therapeutic biotech and pharmaceutical companies, however, moving ... StemBioSys is a development-stage company with novel technologies to isolate and expand specialized stem cell (SC) ... Athersys
Gil Van Bokkelen, Ph.D., Chairman & CEO (NASDAQ: ATHX) Headquarters: Ohio, U.S.
Summary & Highlights for Scmom 2012 Athersys
- The Regen BioPharma business model is to take multiple stem cell therapeutics to and through the human "safety and signal of ...
- Robert Mays, Ph.D., VP of Regenerative Medicine and Head of Neuroscience Cleveland, OH (NASDAQ: ATHX)
- Our next speaker is going to be dr gilvan bachmann of
- Gil Van Bokkelen, Ph.D., Chairman & CEO Cleveland, OH (NASDAQ: ATHX)
- Gil Van Bokkelen, Ph.D., Chairman and CEO Cleveland, OH (NASDAQ: ATHX)
In summary, understanding Scmom 2012 Athersys gives us a better perspective.
